James Galvin

TitleProfessor
InstitutionThomas Jefferson University
DepartmentRadiation Oncology
Address111 S. 11th Street
Philadelphia PA 19107
Phone215-968-3072
vCardDownload vCard

    Collapse Research 
    Collapse research activities and funding
    U24CA180803     (KRY, STEPHEN F)May 26, 2014 - Feb 28, 2025
    NIH
    Imaging and Radiation Oncology Core (IROC) Group
    Role: Co-Principal Investigator

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Li XA, Moughan J, White JR, Freedman GM, Arthur DW, Galvin J, Xiao Y, McNulty S, Lyons JA, Kavadi VS, Fields MT, Mitchell MP, Anderson BM, Lock MI, Kokeny KE, Bazan JG, Currey AD, Hijal T, Cheston SB, Vicini FA. Patterns of failure observed in the two-step institution credentialing process for NRG Oncology/RTOG 1005 (NCT01349322) and lessons learned. Pract Radiat Oncol. 2019 Nov 29. PMID: 31790823.
      Citations:    
    2. Rogers CL, Won M, Vogelbaum MA, Perry A, Ashby LS, Modi JM, Alleman AM, Galvin J, Fogh SE, Youssef E, Deb N, Kwok Y, Robinson CG, Shu HK, Fisher BJ, Panet-Raymond V, McMillan WG, de Groot JF, Zhang P, Mehta MP. High-risk meningioma: Initial outcomes from NRG Oncology/RTOG 0539. Int J Radiat Oncol Biol Phys. 2019 Nov 28. PMID: 31786276.
      Citations:    
    3. Gillison ML, Trotti AM, Harris J, Eisbruch A, Harari PM, Adelstein DJ, Sturgis EM, Burtness B, Ridge JA, Ringash J, Galvin J, Yao M, Koyfman SA, Blakaj DM, Razaq MA, Colevas AD, Beitler JJ, Jones CU, Dunlap NE, Seaward SA, Spencer S, Galloway TJ, Phan J, Dignam JJ, Le QT. Radiotherapy plus cetuximab or cisplatin in human papillomavirus-positive oropharyngeal cancer (NRG Oncology RTOG 1016): a randomised, multicentre, non-inferiority trial. Lancet. 2019 01 05; 393(10166):40-50. PMID: 30449625.
      Citations:    
    4. Moran JM, Molineu A, Kruse JJ, Oldham M, Jeraj R, Galvin JM, Palta JR, Olch AJ. Executive summary of AAPM Report Task Group 113: Guidance for the physics aspects of clinical trials. J Appl Clin Med Phys. 2018 Jun 29. PMID: 29959816.
      Citations:    
    5. Timmerman RD, Paulus R, Pass HI, Gore EM, Edelman MJ, Galvin J, Straube WL, Nedzi LA, McGarry RC, Robinson CG, Schiff PB, Chang G, Loo BW, Bradley JD, Choy H. Stereotactic Body Radiation Therapy for Operable Early-Stage Lung Cancer: Findings From the NRG Oncology RTOG 0618 Trial. JAMA Oncol. 2018 May 31. PMID: 29852037.
      Citations:    
    6. Timmerman RD, Hu C, Michalski JM, Bradley JC, Galvin J, Johnstone DW, Choy H. Long-term Results of Stereotactic Body Radiation Therapy in Medically Inoperable Stage I Non-Small Cell Lung Cancer. JAMA Oncol. 2018 May 31. PMID: 29852036.
      Citations:    
    7. Monroe JI, Boparai K, Xiao Y, Followill D, Galvin JM, Klein EE, Low DA, Moran JM, Zhong H, Sohn JW. NRG Oncology medical physicists' manpower survey quantifying support demands for multi-institutional clinical trials. Pract Radiat Oncol. 2018 Feb 04. PMID: 29907507.
      Citations:    
    8. Rogers L, Zhang P, Vogelbaum MA, Perry A, Ashby LS, Modi JM, Alleman AM, Galvin J, Brachman D, Jenrette JM, De Groot J, Bovi JA, Werner-Wasik M, Knisely JPS, Mehta MP. Intermediate-risk meningioma: initial outcomes from NRG Oncology RTOG 0539. J Neurosurg. 2017 Oct 06; 1-13. PMID: 28984517.
      Citations:    
    9. Chun SG, Hu C, Choy H, Komaki RU, Timmerman RD, Schild SE, Bogart JA, Dobelbower MC, Bosch W, Galvin JM, Kavadi VS, Narayan S, Iyengar P, Robinson CG, Wynn RB, Raben A, Augspurger ME, MacRae RM, Paulus R, Bradley JD. Impact of Intensity-Modulated Radiation Therapy Technique for Locally Advanced Non-Small-Cell Lung Cancer: A Secondary Analysis of the NRG Oncology RTOG 0617 Randomized Clinical Trial. J Clin Oncol. 2017 Jan; 35(1):56-62. PMID: 28034064.
      Citations:    
    10. Al-Hallaq HA, Chmura SJ, Salama JK, Lowenstein JR, McNulty S, Galvin JM, Followill DS, Robinson CG, Pisansky TM, Winter KA, White JR, Xiao Y, Matuszak MM. Benchmark Credentialing Results for NRG-BR001: The First National Cancer Institute-Sponsored Trial of Stereotactic Body Radiation Therapy for Multiple Metastases. Int J Radiat Oncol Biol Phys. 2016 Sep 28. PMID: 27843033.
      Citations:    
    11. Truong MT, Zhang Q, Rosenthal DI, List M, Axelrod R, Sherman E, Weber R, Nguyen-Tân PF, El-Naggar A, Konski A, Galvin J, Schwartz D, Trotti A, Silverman C, Singh A, Godette K, Bonner JA, Jones CU, Garden AS, Shenouda G, Matthiesen C, Le QT, Bruner D. Quality of Life and Performance Status From a Substudy Conducted Within a Prospective Phase 3 Randomized Trial of Concurrent Accelerated Radiation Plus Cisplatin With or Without Cetuximab for Locally Advanced Head and Neck Carcinoma: NRG Oncology Radiation Therapy Oncology Group 0522. Int J Radiat Oncol Biol Phys. 2016 Aug 12. PMID: 27727066.
      Citations:    
    12. Al-Hallaq HA, Chmura S, Salama JK, Winter KA, Robinson CG, Pisansky TM, Borges V, Lowenstein JR, McNulty S, Galvin JM, Followill DS, Timmerman RD, White JR, Xiao Y, Matuszak MM. Rationale of technical requirements for NRG-BR001: The first NCI-sponsored trial of SBRT for the treatment of multiple metastases. Pract Radiat Oncol. 2016 Nov - Dec; 6(6):e291-e298. PMID: 27345129.
      Citations:    
    13. Giaddui T, Chen W, Yu J, Lin L, Simone CB, Yuan L, Gong YU, Wu QJ, Mohan R, Zhang X, Bluett JB, Gillin M, Moore K, O'Meara E, Presley J, Bradley JD, Liao Z, Galvin J, Xiao Y. Establishing the feasibility of the dosimetric compliance criteria of RTOG 1308: phase III randomized trial comparing overall survival after photon versus proton radiochemotherapy for inoperable stage II-IIIB NSCLC. Radiat Oncol. 2016; 11(1):66. PMID: 27142674.
      Citations:    
    14. Gong YU, Yu J, Pang D, Zhen H, Galvin J, Xiao Y. Automated Extraction of Dose/Volume Statistics for Radiotherapy-Treatment-Plan Evaluation in Clinical-Trial Quality Assurance. Front Oncol. 2016; 6:47. PMID: 26973814.
      Citations:    
    15. Giaddui T, Yu J, Manfredi D, Linnemann N, Hunter J, O'Meara E, Galvin J, Bialecki B, Xiao Y. Structures' validation profiles in Transmission of Imaging and Data (TRIAD) for automated National Clinical Trials Network (NCTN) clinical trial digital data quality assurance. Pract Radiat Oncol. 2016 Sep-Oct; 6(5):331-3. PMID: 27053498.
      Citations:    
    16. FitzGerald TJ, Bishop-Jodoin M, Followill DS, Galvin J, Knopp MV, Michalski JM, Rosen MA, Bradley JD, Shankar LK, Laurie F, Cicchetti MG, Moni J, Coleman CN, Deye JA, Capala J, Vikram B. Imaging and Data Acquisition in Clinical Trials for Radiation Therapy. Int J Radiat Oncol Biol Phys. 2016 Feb 1; 94(2):404-11. PMID: 26853346.
      Citations:    
    17. Xiao Y, Kry SF, Popple R, Yorke E, Papanikolaou N, Stathakis S, Xia P, Huq S, Bayouth J, Galvin J, Yin FF. Flattening filter-free accelerators: a report from the AAPM Therapy Emerging Technology Assessment Work Group. J Appl Clin Med Phys. 2015; 16(3):5219. PMID: 26103482.
      Citations:    
    18. Moore KL, Schmidt R, Moiseenko V, Olsen LA, Tan J, Xiao Y, Galvin J, Pugh S, Seider MJ, Dicker AP, Bosch W, Michalski J, Mutic S. Quantifying Unnecessary Normal Tissue Complication Risks due to Suboptimal Planning: A Secondary Study of RTOG 0126. Int J Radiat Oncol Biol Phys. 2015 Jun 1; 92(2):228-35. PMID: 25847605.
      Citations:    
    19. Bruner DW, Hunt D, Michalski JM, Bosch WR, Galvin JM, Amin M, Xiao C, Bahary JP, Patel M, Chafe S, Rodrigues G, Lau H, Duclos M, Baikadi M, Deshmukh S, Sandler HM. Preliminary patient-reported outcomes analysis of 3-dimensional radiation therapy versus intensity-modulated radiation therapy on the high-dose arm of the Radiation Therapy Oncology Group (RTOG) 0126 prostate cancer trial. Cancer. 2015 Jul 15; 121(14):2422-30. PMID: 25847819.
      Citations:    
    20. Gondi V, Cui Y, Mehta MP, Manfredi D, Xiao Y, Galvin JM, Rowley H, Tome WA. Real-Time Pretreatment Review Limits Unacceptable Deviations on a Cooperative Group Radiation Therapy Technique Trial: Quality Assurance Results of RTOG 0933. Int J Radiat Oncol Biol Phys. 2015 Mar 1; 91(3):564-70. PMID: 25586708.
      Citations:    
    21. Melidis C, Bosch WR, Izewska J, Fidarova E, Zubizarreta E, Ulin K, Ishikura S, Followill D, Galvin J, Haworth A, Besuijen D, Clark CH, Miles E, Aird E, Weber DC, Hurkmans CW, Verellen D. Global harmonization of quality assurance naming conventions in radiation therapy clinical trials. Int J Radiat Oncol Biol Phys. 2014 Dec 1; 90(5):1242-9. PMID: 25539374.
      Citations:    
    22. Yu J, Straube W, Mayo C, Giaddui T, Bosch W, Ulin K, Kry SF, Galvin J, Xiao Y. Radiation therapy digital data submission process for national clinical trials network. Int J Radiat Oncol Biol Phys. 2014 Oct 1; 90(2):466-7. PMID: 25304799.
      Citations:    
    23. Ang KK, Zhang Q, Rosenthal DI, Nguyen-Tan PF, Sherman EJ, Weber RS, Galvin JM, Bonner JA, Harris J, El-Naggar AK, Gillison ML, Jordan RC, Konski AA, Thorstad WL, Trotti A, Beitler JJ, Garden AS, Spanos WJ, Yom SS, Axelrod RS. Randomized phase III trial of concurrent accelerated radiation plus cisplatin with or without cetuximab for stage III to IV head and neck carcinoma: RTOG 0522. J Clin Oncol. 2014 Sep 20; 32(27):2940-50. PMID: 25154822.
      Citations:    
    24. Cui Y, Chen W, Kong FM, Olsen LA, Beatty RE, Maxim PG, Ritter T, Sohn JW, Higgins J, Galvin JM, Xiao Y. Contouring variations and the role of atlas in non-small cell lung cancer radiation therapy: Analysis of a multi-institutional preclinical trial planning study. Pract Radiat Oncol. 2015 Mar-Apr; 5(2):e67-75. PMID: 25413413.
      Citations:    
    25. Melidis C, Bosch WR, Izewska J, Fidarova E, Zubizarreta E, Ishikura S, Followill D, Galvin J, Xiao Y, Ebert MA, Kron T, Clark CH, Miles EA, Aird EG, Weber DC, Ulin K, Verellen D, Hurkmans CW. Radiation therapy quality assurance in clinical trials - Global harmonisation group. Radiother Oncol. 2014 Jun; 111(3):327-9. PMID: 24813094.
      Citations:    
    26. Gardner SJ, Studenski MT, Giaddui T, Cui Y, Galvin J, Yu Y, Xiao Y. Investigation into image quality and dose for different patient geometries with multiple cone-beam CT systems. Med Phys. 2014 Mar; 41(3):031908. PMID: 24593726.
      Citations:    
    27. Michalski JM, Yan Y, Watkins-Bruner D, Bosch WR, Winter K, Galvin JM, Bahary JP, Morton GC, Parliament MB, Sandler HM. Preliminary toxicity analysis of 3-dimensional conformal radiation therapy versus intensity modulated radiation therapy on the high-dose arm of the radiation therapy oncology group 0126 prostate cancer trial. Int J Radiat Oncol Biol Phys. 2013 Dec 1; 87(5):932-8. PMID: 24113055.
      Citations:    
    28. Seung SK, Larson DA, Galvin JM, Mehta MP, Potters L, Schultz CJ, Yajnik SV, Hartford AC, Rosenthal SA. American College of Radiology (ACR) and American Society for Radiation Oncology (ASTRO) Practice Guideline for the Performance of Stereotactic Radiosurgery (SRS). Am J Clin Oncol. 2013 Jun; 36(3):310-5. PMID: 23681017.
      Citations:    
    29. Giaddui T, Cui Y, Galvin J, Yu Y, Xiao Y. Comparative dose evaluations between XVI and OBI cone beam CT systems using Gafchromic XRQA2 film and nanoDot optical stimulated luminescence dosimeters. Med Phys. 2013 Jun; 40(6):062102. PMID: 23718600.
      Citations:    
    30. Fitzgerald TJ, Bishop-Jodoin M, Bosch WR, Curran WJ, Followill DS, Galvin JM, Hanusik R, King SR, Knopp MV, Laurie F, O'Meara E, Michalski JM, Saltz JH, Schnall MD, Schwartz L, Ulin K, Xiao Y, Urie M. Future vision for the quality assurance of oncology clinical trials. Front Oncol. 2013; 3:31. PMID: 23508883.
      Citations:    
    31. Wolden SL, Rabinovitch RA, Bittner NH, Galvin JM, Giap HB, Schomberg PJ, Rosenthal SA. American College of Radiology (ACR) and American Society for Radiation Oncology (ASTRO) Practice Guideline for the Performance of Total Body Irradiation (TBI). Am J Clin Oncol. 2013 Feb; 36(1):97-101. PMID: 23334484.
      Citations:    
    32. Kry SF, Alvarez P, Molineu A, Amador C, Galvin J, Followill DS. Algorithms Used in Heterogeneous Dose Calculations Show Systematic Differences as Measured With the Radiological Physics Center's Anthropomorphic Thorax Phantom Used for RTOG Credentialing. Int J Radiat Oncol Biol Phys. 2013 Jan 1; 85(1):e95-e100. PMID: 23237006.
      Citations:    
    33. Followill DS, Urie M, Galvin JM, Ulin K, Xiao Y, Fitzgerald TJ. Credentialing for participation in clinical trials. Front Oncol. 2012; 2:198. PMID: 23272300.
      Citations:    
    34. Hartford AC, Galvin JM, Beyer DC, Eichler TJ, Ibbott GS, Kavanagh B, Schultz CJ, Rosenthal SA. American College of Radiology (ACR) and American Society for Radiation Oncology (ASTRO) Practice Guideline for Intensity-modulated Radiation Therapy (IMRT). Am J Clin Oncol. 2012 Dec; 35(6):612-7. PMID: 23165357.
      Citations:    
    35. Machtay M, Moughan J, Farach A, Martin-O'Meara E, Galvin J, Garden AS, Weber RS, Cooper JS, Forastiere A, Ang KK. Hypopharyngeal Dose Is Associated With Severe Late Toxicity in Locally Advanced Head-and-Neck Cancer: An RTOG Analysis. Int J Radiat Oncol Biol Phys. 2012 Nov 15; 84(4):983-9. PMID: 23078898.
      Citations:    
    36. Willett CG, Moughan J, O'Meara E, Galvin JM, Crane CH, Winter K, Manfredi D, Rich TA, Rabinovitch R, Lustig R, Machtay M, Curran WJ. Compliance with therapeutic guidelines in Radiation Therapy Oncology Group prospective gastrointestinal clinical trials. Radiother Oncol. 2012 Oct; 105(1):9-13. PMID: 23084596.
      Citations:    
    37. Chen W, Cui Y, He Y, Yu Y, Galvin J, Hussaini YM, Xiao Y. Application of Dempster-Shafer theory in dose response outcome analysis. Phys Med Biol. 2012 Sep 7; 57(17):5575-85. PMID: 22892545.
      Citations:    
    38. Cui Y, Galvin JM, Parker W, Breen S, Yin FF, Cai J, Papiez LS, Li XA, Bednarz G, Chen W, Xiao Y. Implementation of remote 3-dimensional image guided radiation therapy quality assurance for radiation therapy oncology group clinical trials. Int J Radiat Oncol Biol Phys. 2013 Jan 1; 85(1):271-7. PMID: 22541964.
      Citations:    
    39. Li J, Galvin J, Harrison A, Timmerman R, Yu Y, Xiao Y. Dosimetric verification using monte carlo calculations for tissue heterogeneity-corrected conformal treatment plans following RTOG 0813 dosimetric criteria for lung cancer stereotactic body radiotherapy. Int J Radiat Oncol Biol Phys. 2012 Oct 1; 84(2):508-13. PMID: 22365630.
      Citations:    
    40. Giaddui T, Cui Y, Galvin J, Chen W, Yu Y, Xiao Y. Characteristics of Gafchromic XRQA2 films for kV image dose measurement. Med Phys. 2012 Feb; 39(2):842-50. PMID: 22320794.
      Citations:    
    41. Santanam L, Hurkmans C, Mutic S, van Vliet-Vroegindeweij C, Brame S, Straube W, Galvin J, Tripuraneni P, Michalski J, Bosch W. Standardizing naming conventions in radiation oncology. Int J Radiat Oncol Biol Phys. 2012 Jul 15; 83(4):1344-9. PMID: 22245204.
      Citations:    
    42. Moran JM, Dempsey M, Eisbruch A, Fraass BA, Galvin JM, Ibbott GS, Marks LB. Safety considerations for IMRT: executive summary. Med Phys. 2011 Sep; 38(9):5067-72. PMID: 21978051.
      Citations:    
    43. Moran JM, Dempsey M, Eisbruch A, Fraass BA, Galvin JM, Ibbott GS, Marks LB. Safety considerations for IMRT: Executive summary. Pract Radiat Oncol. 2011 Jul-Sep; 1(3):190-5. PMID: 25740119.
      Citations:    
    44. Cui Y, Galvin JM, Straube WL, Bosch WR, Purdy JA, Li XA, Xiao Y. Multi-system verification of registrations for image-guided radiotherapy in clinical trials. Int J Radiat Oncol Biol Phys. 2011 Sep 1; 81(1):305-12. PMID: 21236596.
      Citations:    
    45. Benedict SH, Yenice KM, Followill D, Galvin JM, Hinson W, Kavanagh B, Keall P, Lovelock M, Meeks S, Papiez L, Purdie T, Sadagopan R, Schell MC, Salter B, Schlesinger DJ, Shiu AS, Solberg T, Song DY, Stieber V, Timmerman R, Tomé WA, Verellen D, Wang L, Yin FF. Stereotactic body radiation therapy: the report of AAPM Task Group 101. Med Phys. 2010 Aug; 37(8):4078-101. PMID: 20879569.
      Citations:    
    46. Timmerman R, Paulus R, Galvin J, Michalski J, Straube W, Bradley J, Fakiris A, Bezjak A, Videtic G, Johnstone D, Fowler J, Gore E, Choy H. Stereotactic body radiation therapy for inoperable early stage lung cancer. JAMA. 2010 Mar 17; 303(11):1070-6. PMID: 20233825.
      Citations:    
    47. Podder TK, Bednarz G, Yu Y, Galvin JM. Physical characterization and comparison of two commercially available micro-MLCs. Phys Med. 2011 Jan; 27(1):52-7. PMID: 20199884.
      Citations:    
    48. Potters L, Gaspar LE, Kavanagh B, Galvin JM, Hartford AC, Hevezi JM, Kupelian PA, Mohiden N, Samuels MA, Timmerman R, Tripuraneni P, Vlachaki MT, Xing L, Rosenthal SA. American Society for Therapeutic Radiology and Oncology (ASTRO) and American College of Radiology (ACR) practice guidelines for image-guided radiation therapy (IGRT). Int J Radiat Oncol Biol Phys. 2010 Feb 1; 76(2):319-25. PMID: 20117284.
      Citations:    
    49. Potters L, Kavanagh B, Galvin JM, Hevezi JM, Janjan NA, Larson DA, Mehta MP, Ryu S, Steinberg M, Timmerman R, Welsh JS, Rosenthal SA. American Society for Therapeutic Radiology and Oncology (ASTRO) and American College of Radiology (ACR) practice guideline for the performance of stereotactic body radiation therapy. Int J Radiat Oncol Biol Phys. 2010 Feb 1; 76(2):326-32. PMID: 20117285.
      Citations:    
    50. Den RB, Doemer A, Kubicek G, Bednarz G, Galvin JM, Keane WM, Xiao Y, Machtay M. Daily image guidance with cone-beam computed tomography for head-and-neck cancer intensity-modulated radiotherapy: a prospective study. Int J Radiat Oncol Biol Phys. 2010 Apr; 76(5):1353-9. PMID: 19540071.
      Citations:    
    51. Xiao Y, Papiez L, Paulus R, Timmerman R, Straube WL, Bosch WR, Michalski J, Galvin JM. Dosimetric evaluation of heterogeneity corrections for RTOG 0236: stereotactic body radiotherapy of inoperable stage I-II non-small-cell lung cancer. Int J Radiat Oncol Biol Phys. 2009 Mar 15; 73(4):1235-42. PMID: 19251095.
      Citations:    
    52. Bednarz G, Machtay M, Werner-Wasik M, Downes B, Bogner J, Hyslop T, Galvin J, Evans J, Curran W, Andrews D. Report on a randomized trial comparing two forms of immobilization of the head for fractionated stereotactic radiotherapy. Med Phys. 2009 Jan; 36(1):12-7. PMID: 19235368.
      Citations:    
    53. Galvin JM, Xiao Y, Curran WJ. Re: Intensity-modulated radiation therapy dose prescription, recording, and delivery: patterns of variability among institutions and treatment planning systems. J Natl Cancer Inst. 2008 Sep 3; 100(17):1264; author reply 1265-7. PMID: 18728287.
      Citations:    
    54. Censor Y, Ben-Israel A, Xiao Y, Galvin JM. On Linear Infeasibility Arising in Intensity-Modulated Radiation Therapy Inverse Planning. Linear Algebra Appl. 2008 Mar 1; 428(5-6):1406-1420. PMID: 19562040.
      Citations:    
    55. Galvin JM, Bednarz G. Quality assurance procedures for stereotactic body radiation therapy. Int J Radiat Oncol Biol Phys. 2008; 71(1 Suppl):S122-5. PMID: 18406909.
      Citations:    
    56. Showalter TN, Nawaz AO, Xiao Y, Galvin JM, Valicenti RK. A cone beam CT-Based Study for Clinical Target Definition Using Pelvic Anatomy During Postprostatectomy Radiotherapy. Int J Radiat Oncol Biol Phys. 2008 Feb 1; 70(2):431-6. PMID: 17869021.
      Citations:    
    57. Galvin JM, De Neve W. Intensity modulating and other radiation therapy devices for dose painting. J Clin Oncol. 2007 Mar 10; 25(8):924-30. PMID: 17350940.
      Citations:    
    58. Galvin JM. Alternative methods for intensity-modulated radiation therapy inverse planning and dose delivery. Semin Radiat Oncol. 2006 Oct; 16(4):218-23. PMID: 17010904.
      Citations:    
    59. Timmerman R, Galvin J, Michalski J, Straube W, Ibbott G, Martin E, Abdulrahman R, Swann S, Fowler J, Choy H. Accreditation and quality assurance for Radiation Therapy Oncology Group: Multicenter clinical trials using Stereotactic Body Radiation Therapy in lung cancer. Acta Oncol. 2006; 45(7):779-86. PMID: 16982540.
      Citations:    
    60. Xiao Y, Michalski D, Censor Y, Galvin JM. Inherent smoothness of intensity patterns for intensity modulated radiation therapy generated by simultaneous projection algorithms. Phys Med Biol. 2004 Jul 21; 49(14):3227-45. PMID: 15357194.
      Citations:    
    61. Chen Y, Hou Q, Galvin JM. A graph-searching method for MLC leaf sequencing under constraints. Med Phys. 2004 Jun; 31(6):1504-11. PMID: 15259654.
      Citations:    
    62. Galvin JM, Ezzell G, Eisbrauch A, Yu C, Butler B, Xiao Y, Rosen I, Rosenman J, Sharpe M, Xing L, Xia P, Lomax T, Low DA, Palta J. Implementing IMRT in clinical practice: a joint document of the American Society for Therapeutic Radiology and Oncology and the American Association of Physicists in Medicine. Int J Radiat Oncol Biol Phys. 2004 Apr 1; 58(5):1616-34. PMID: 15050343.
      Citations:    
    63. Michalski D, Xiao Y, Censor Y, Galvin JM. The dose-volume constraint satisfaction problem for inverse treatment planning with field segments. Phys Med Biol. 2004 Feb 21; 49(4):601-16. PMID: 15005168.
      Citations:    
    64. Xiao Y, Werner-Wasik M, Michalski D, Houser C, Bednarz G, Curran W, Galvin J. Comparison of three IMRT inverse planning techniques that allow for partial esophagus sparing in patients receiving thoracic radiation therapy for lung cancer. Med Dosim. 2004; 29(3):210-6. PMID: 15324918.
      Citations:    
    65. Hou Q, Wang J, Chen Y, Galvin JM. Beam orientation optimization for IMRT by a hybrid method of the genetic algorithm and the simulated dynamics. Med Phys. 2003 Sep; 30(9):2360-7. PMID: 14528958.
      Citations:    
    66. Ezzell GA, Galvin JM, Low D, Palta JR, Rosen I, Sharpe MB, Xia P, Xiao Y, Xing L, Yu CX. Guidance document on delivery, treatment planning, and clinical implementation of IMRT: report of the IMRT Subcommittee of the AAPM Radiation Therapy Committee. Med Phys. 2003 Aug; 30(8):2089-115. PMID: 12945975.
      Citations:    
    67. Hou Q, Wang J, Chen Y, Galvin JM. An optimization algorithm for intensity modulated radiotherapy--the simulated dynamics with dose-volume constraints. Med Phys. 2003 Jan; 30(1):61-8. PMID: 12557980.
      Citations:    
    68. Hossain M, Houser CJ, Galvin JM. Output variation from an intensity modulating dynamic collimator. Med Phys. 2002 Aug; 29(8):1693-7. PMID: 12201415.
      Citations:    
    69. Bednarz G, Michalski D, Houser C, Huq MS, Xiao Y, Anne PR, Galvin JM. The use of mixed-integer programming for inverse treatment planning with pre-defined field segments. Phys Med Biol. 2002 Jul 7; 47(13):2235-45. PMID: 12164584.
      Citations:    
    70. Huq MS, Das IJ, Steinberg T, Galvin JM. A dosimetric comparison of various multileaf collimators. Phys Med Biol. 2002 Jun 21; 47(12):N159-70. PMID: 12118609.
      Citations:    
    71. Song H, Xiao Y, Galvin JM. Comparison of characteristics of photon and electron beams generated by Philips/Elekta and Varian linear accelerators. Med Phys. 2002 Jun; 29(6):960-6. PMID: 12094991.
      Citations:    
    72. Chen Y, Michalski D, Houser C, Galvin JM. A deterministic iterative least-squares algorithm for beam weight optimization in conformal radiotherapy. Phys Med Biol. 2002 May 21; 47(10):1647-58. PMID: 12069084.
      Citations:    
    Galvin's Networks
    Click the
    Explore
    buttons for more information and interactive visualizations!
    Concepts (127)
    Explore
    _
    Co-Authors (11)
    Explore
    _
    Similar People (60)
    Explore
    _
    Same Department Expand Description
    Explore
    _